Evaluation of the Acute Effect of Water-Pipe Smoking on the Respiratory System

June 10, 2013 updated by: Rambam Health Care Campus

Title: The acute effect of water pipe smoking on exhaled nitric oxide (eNO) and exhaled breath condensate (EBC) pulmonary function tests in healthy volunteers

Objectives: To evaluate the acute effect of one cession of water pipe smoking on airway inflammation as assessed by exhaled nitric oxide (eNO) and exhaled breath condensate (EBC) in healthy volunteers.

Design: Prospective study evaluating these parameters before and after 30 minutes of water pipe smoking . The changes in inflammatory parameters pre and post smoking will be evaluated blindly.

Sample size: 100 participants Participant selection: Adults subjects who regularly smoke water pipe . Intervention: Each subject will undergo evaluation including a respiratory questionnaire , pulmonary function tests , exhaled nitric oxide (eNO) and exhaled breath condensate (EBC) and carboxy- hemoglobin levels . All measurements will be evaluated before and after one cession of 30 minutes water pipe smoking

Primary outcome parameter: Change in carboxy- hemoglobin Secondary outcome parameter:Change in peripheral eosinophils count, pulmonary function tests, change in FeNO, and in inflammatory parameters in EBC before and after water pipe smoking

Study Overview

Study Type

Observational

Enrollment (Actual)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel, 31096
        • Rambam Health Care Campus
      • Haifa, Israel
        • Rambam Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Normal People who have smoked Water-pipe, at least once before.

Description

Inclusion Criteria:

  • Age > 18 Y.O.
  • Have smoked Water-pipe at least once before.

Exclusion Criteria:

  • Breast feeding Women.
  • S/P Bacterial Or Viral infection, Last 2 weeks
  • P.O. Steroids
  • Water-pipe smoking, last 24 hours
  • Cigarette smoking, last 6 hours
  • Intensive exposure to smoke (fire), last 24 hours
  • S/P Intensive Care Hospitalization, last 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
carboxy- hemoglobin
Time Frame: before and immediatly after 30 min of smoking
blood test
before and immediatly after 30 min of smoking

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eosinophils count
Time Frame: before and immediatly after 30 min of smoking
blood test
before and immediatly after 30 min of smoking
heart rate
Time Frame: before and immediatly after 30 min of smoking
heart beats count
before and immediatly after 30 min of smoking
Respiratory rate
Time Frame: before and immediatly after 30 min of smoking
Respiratory rate
before and immediatly after 30 min of smoking
Blood pressure
Time Frame: before and immediatly after 30 min of smoking
Non Invasive Blood pressure mesaurement
before and immediatly after 30 min of smoking
Spirometry
Time Frame: before and immediatly after 30 min of smoking
Pulmonary function test
before and immediatly after 30 min of smoking
Visual Analog Score 1-10 (1=bad 10=good)
Time Frame: before and immediatly after 30 min of smoking
Questionnaire
before and immediatly after 30 min of smoking
Exhaled breath Condensate
Time Frame: before and immediatly after 30 min of smoking
R-tube tests
before and immediatly after 30 min of smoking
Fractional Exhaled NO
Time Frame: before and immediatly after 30 min of smoking
Exhaled NO test
before and immediatly after 30 min of smoking

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lea Bentur, Prof., Rambam Health Care Campus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2009

Primary Completion (Actual)

August 1, 2010

Study Completion (Actual)

August 1, 2010

Study Registration Dates

First Submitted

July 6, 2010

First Submitted That Met QC Criteria

July 6, 2010

First Posted (Estimate)

July 7, 2010

Study Record Updates

Last Update Posted (Estimate)

June 11, 2013

Last Update Submitted That Met QC Criteria

June 10, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • RMC-0219-09

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vital Signs

3
Subscribe